Epidemic of COVID-Associated Mucormycosis in India and a road ahead

COVID-associated Mucormycosis (CAM) was a peak-hour crisis in India. The situation arose from an unprecedented ICU workload of critical COVID-19 cases, insufficient resources and the impaired immune status of the patient. We recommend strong preventive measures, chemoprophylaxis and Amphotericin-B n...

Full description

Saved in:
Bibliographic Details
Main Authors: S. Sharma (Author), P. Sharma (Author), U. K. Chandra (Author), S. Javed (Author), A. Nambiar (Author), V. K. Sharma (Author)
Format: Book
Published: Sri Lanka College of Internal Medicine, 2023-02-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:COVID-associated Mucormycosis (CAM) was a peak-hour crisis in India. The situation arose from an unprecedented ICU workload of critical COVID-19 cases, insufficient resources and the impaired immune status of the patient. We recommend strong preventive measures, chemoprophylaxis and Amphotericin-B nebulisation for the effective management of CAM.
Item Description:10.4038/ajim.v2i1.71
2827-7260